v3.26.1
Significant Accounting Policies (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Net revenues $ 21,796 $ (0)
Net loss 8,644,897 2,439,625
Net cash flows from operating activities 5,413,736 3,911,004
Accumulated deficit 34,667,026 26,022,129
Cash FDIC limit 250,000  
Cash uninsured amount 0 3,519,510
Research and development costs $ 2,086,574 $ 492,660
Derivative liabilities current not disclosed flag true  
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Number of stock options 0 1,359,375
Restricted Stock Units (RSUs) [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Number of stock options 1,626,037 1,626,037
Share-Based Payment Arrangement, Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Number of stock options 11,726,093 10,633,988